Announcements Trials
Browse Landscape

Phase

Phase 2 33Phase 1 22Phase 1/2 7Phase 3 6Phase EARLY_PHASE1 5Phase NA 4Phase 2/3 4Phase 4 2

Status

Completed 48Unknown 23Terminated 15Withdrawn 9Not yet recruiting 4Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 3UNKNOWN 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Plasma cell 1Lymphoid 1

Conditions

Triple Negative Breast Neoplasms 1Multiple Myeloma 1Lymphoma, Large B-Cell, Diffuse 1Breast Neoplasms 1

Interventions

Exercise 27Standard of Care 24Blood Specimen Collection 18Interviews as Topic 16Educational Status 13Radiosurgery 12Drug Therapy 12Methods 11Surgical Procedures, Operative 10Surveys and Questionnaires 9Saline Solution 9Acupuncture Therapy 9Therapeutics 8Radiotherapy 8Paclitaxel 8Early Intervention, Educational 8Palliative Care 7Magnetic Resonance Spectroscopy 7Electroacupuncture 7Cryotherapy 7Specimen Handling 6Preoperative Exercise 6Practice Guidelines as Topic 6Dexmedetomidine 6Control Groups 6Colonoscopy 6Carboplatin 6tislelizumab 5Resistance Training 5Radiofrequency Ablation 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Not yet recruiting × Cyclophosphamide × Clear all
NCT06975644 2025-05-22

Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)

Zhejiang Provincial People's Hospital

Phase NA Not yet recruiting
55 enrolled
Breast

Triple Negative Breast Neoplasms

NCT06472479 2024-06-28

LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma

The First Affiliated Hospital with Nanjing Medical University

Phase NA Not yet recruiting
66 enrolled
Plasma cell

Multiple Myeloma

NCT05990985 2023-08-18

The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission.

The First Hospital of Jilin University

Phase NA Not yet recruiting
20 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05287308 2022-03-31

Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study

ChineseAMS

Phase NA Not yet recruiting
500 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡